Press releases
- Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography
- Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
- Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing
- Hologic to Unveil Groundbreaking AI Research at ECR 2024
- Hologic to Webcast Presentations at Upcoming Investor Conferences
- Hologic Announces First and Only FDA-Cleared Digital Cytology System – Genius™ Digital Diagnostics System
- Hologic Announces Financial Results for First Quarter of Fiscal 2024
More ▼
Key statistics
As of last trade, Hologic Inc (HOLX:DEU) traded at 70.00, 15.59% above the 52 week low of 60.56 set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 70.50 |
---|---|
High | 71.00 |
Low | 70.00 |
Bid | 70.50 |
Offer | 71.00 |
Previous close | 71.50 |
Average volume | 51.00 |
---|---|
Shares outstanding | 234.73m |
Free float | 233.00m |
P/E (TTM) | 35.99 |
Market cap | 17.77bn USD |
EPS (TTM) | 2.10 USD |
Data delayed at least 15 minutes, as of Apr 25 2024.
More ▼